Published in J Intensive Care Soc on December 09, 2014
Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med (2011) 3.87
THE CULTURE OF WHOLE ORGANS. Science (1935) 3.84
Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci U S A (2009) 3.84
Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med (2003) 3.54
The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med (2005) 2.57
Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg (2000) 2.00
First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg (2007) 1.96
Stimulation of alveolar epithelial fluid clearance in human lungs by exogenous epinephrine. Crit Care Med (2006) 1.81
Impact of a lung transplantation donor-management protocol on lung donation and recipient outcomes. Am J Respir Crit Care Med (2006) 1.80
Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant (2008) 1.77
Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: a pilot study of 12 patients. Lancet (2012) 1.75
Functional repair of human donor lungs by IL-10 gene therapy. Sci Transl Med (2009) 1.72
Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med (2002) 1.69
General overview of lung transplantation and review of organ allocation. Proc Am Thorac Soc (2009) 1.68
Early results in transplantation of initially rejected donor lungs after ex vivo lung perfusion: a case-control study. Eur J Cardiothorac Surg (2013) 1.63
Inhibition of nuclear factor kappaB by IkappaB superrepressor gene transfer ameliorates ischemia-reperfusion injury after experimental lung transplantation. J Thorac Cardiovasc Surg (2005) 1.52
Volutrauma, but not atelectrauma, induces systemic cytokine production by lung-marginated monocytes. Crit Care Med (2014) 1.52
Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+. Circ Res (1998) 1.50
Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation. Am J Transplant (2008) 1.47
Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am J Transplant (2009) 1.43
Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process. Am J Physiol Heart Circ Physiol (2010) 1.43
Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med (2001) 1.29
Role of lung-marginated monocytes in an in vivo mouse model of ventilator-induced lung injury. Am J Respir Crit Care Med (2009) 1.25
Pattern of injury and the role of neutrophils in reperfusion injury of rat lung. J Surg Res (1995) 1.23
Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo. Ann Thorac Surg (2003) 1.17
A review of lung transplant donor acceptability criteria. J Heart Lung Transplant (2003) 1.16
Primary graft dysfunction: definition, risk factors, short- and long-term outcomes. Semin Respir Crit Care Med (2010) 1.13
Lung-marginated monocytes modulate pulmonary microvascular injury during early endotoxemia. Am J Respir Crit Care Med (2005) 1.08
Failure to express the P-selectin gene or P-selectin blockade confers early pulmonary protection after lung ischemia or transplantation. Proc Natl Acad Sci U S A (1997) 1.08
Oxygen-dependent lipid peroxidation during lung ischemia. J Clin Invest (1991) 1.07
Pre-implantation multiple cytokine mRNA expression analysis of donor lung grafts predicts survival after lung transplantation in humans. Am J Transplant (2006) 1.06
Clinical ex vivo lung perfusion--pushing the limits. Am J Transplant (2012) 1.04
Early outcomes of bilateral sequential single lung transplantation after ex-vivo lung evaluation and reconditioning. J Heart Lung Transplant (2011) 1.02
Adhesion molecules contribute to ischemia and reperfusion-induced injury in the isolated rat lung. J Appl Physiol (1985) (1995) 1.01
Lung donor selection and management. Proc Am Thorac Soc (2009) 0.97
The hemodynamic mechanisms of lung injury and systemic inflammatory response following brain death in the transplant donor. Am J Transplant (2005) 0.94
Anoxia-reoxygenation versus ischemia in isolated rat lungs. Am J Physiol (1997) 0.91
Up-regulation of endothelial nitric oxide synthase inhibits pulmonary leukocyte migration following lung ischemia-reperfusion in mice. Am J Pathol (2004) 0.90
The early release of interleukin-2, tumor necrosis factor-alpha and interferon-gamma after ischemia reperfusion injury in the lung allograft. Transplantation (1994) 0.90
The effect of ex vivo lung perfusion on microbial load in human donor lungs. J Heart Lung Transplant (2014) 0.88
Fibrinolytic treatment improves the quality of lungs retrieved from non-heart-beating donors. J Heart Lung Transplant (2007) 0.86
Ex vivo reconditioning of marginal donor lungs injured by acid aspiration. J Heart Lung Transplant (2008) 0.86
Early hemodynamic injury during donor brain death determines the severity of primary graft dysfunction after lung transplantation. Am J Transplant (2007) 0.85
Ex vivo lung perfusion to improve donor lung function and increase the number of organs available for transplantation. Transpl Int (2014) 0.85
The clinical potential of ex vivo lung perfusion. Expert Rev Respir Med (2012) 0.85
N-acetylcysteine attenuates lung ischemia-reperfusion injury after lung transplantation. Ann Thorac Surg (2007) 0.82
Lung transplantation from out-of-hospital non-heart-beating lung donors. one-year experience and results. J Heart Lung Transplant (2005) 0.81
Platelet-activating factor mediates intercellular adhesion molecule-1-dependent radical production in the nonhypoxic ischemia rat lung. Am J Respir Cell Mol Biol (1998) 0.78
Lung reperfusion injury is reduced by inhibiting a CD18-dependent mechanism. J Heart Lung Transplant (1993) 0.75